Squarepoint’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History
Bought
Maintained
Sold
Squarepoint's CINC Position: Q1 2023 in Review
Squarepoint sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 33,058 shares — an estimated $406K sold.
Squarepoint first reported a position in CINC in Q4 2022 and held it in 1 quarter. The position peaked at $406K in Q4 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.
- Squarepoint reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
- Squarepoint sold 33,058 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $406K.
- Squarepoint first reported a position in CinCor Pharma, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
- Squarepoint's CinCor Pharma, Inc. Common Stock position peaked at $406K in Q4 2022.
- 0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.
Based on Squarepoint's 13F filing for Q1 2023, filed 15 May 2023.